The Therapeutic Potential of MicroRNAs Delivered By Mesenchymal Stem Cells in Parkinson’s Disease, Alzheimer’s Disease, and Stroke: A Systematic Review of Preclinical Studies

Dominika Przywara, Alicja Petniak, Paulina Gil-Kulik · 2026

Read The Therapeutic Potential of MicroRNAs Delivered By Mesenchymal Stem Cells in Parkinson’s Disease, Alzheimer’s Disease, and Stroke: A Systematic Review of Preclinical Studies by Dominika Przywara, Alicja Petniak, Paulina Gil-Kulik (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13633960.txt.

Description

Dominika Przywara, Alicja Petniak, and Paulina Gil-Kulik review stem cell microRNAs as candidate treatments for three brain disorders. Their 2026 systematic review covers Parkinson's disease, Alzheimer's disease, and stroke. Aging populations keep raising the counts of all three, while current care mostly eases symptoms without slowing the diseases.

PubMed and Scopus were searched under standard review guidelines, and bias was scored with two tools for animal studies. Thirty-seven preclinical papers qualified: nine on Parkinson's, ten on Alzheimer's, and eighteen on stroke. Mesenchymal stem cells release tiny RNA strands that tune cell death, growth, inflammation, and stress responses. Four strands stood out across the studies for their repeat effects. The authors weigh this early animal evidence and the distance left to human use.

Catalog record

CREATORDominika Przywara, Alicja Petniak, Paulina Gil-Kulik
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE63 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13633960

Browse the full library · About the Tower of Babel